Fig. 4

In vivo antitumor effect. a Tumor growth profiles during the experimental period of 4T1 tumor-bearing mice in different groups. b Bodyweight of 4T1 tumor-bearing mice under different treatments. c The tumor weight at the end of the experiment. d Survival rate of 4T1 tumor-bearing mice. e Representative flow cytometry plots of CD4⁺ T cells by different treatments. f Quantitative analysis of the percentage of CD4⁺ T cells. g Representative flow cytometry plots of CD8⁺ T cells by different treatments. h Quantitative analysis of the percentage of CD8⁺ T cells. The mean ± standard deviation is reported (n = 6) *p < 0.05, **p < 0.01, ***p < 0.001